Proteomic analysis reveals drug accessible cell surface N-glycoproteins of primary and established glioblastoma cell lines

Journal of Proteome Research

Volumn 11, Issue 10, 2012, Pages 4885-4893

  Bock, Thomas ^a,e   Moest, Hansjoerg ^a   Omasits, Ulrich ^a   Dolski, Silvia ^b   Lundberg, Emma ^c   Frei, Andreas ^a   Hofmann, Andreas ^a,f   Bausch Fluck, Damaris ^a   Jacobs, Andrea ^a   Krayenbuehl, Niklaus ^b   Uhlen, Mathias ^c   Aebersold, Ruedi ^a,d   Frei, Karl ^b   Wollscheid, Bernd ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ALBANOVA UNIVERSITY CENTER   (Sweden)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e NOVARTIS PHARMA AG   (Switzerland)

^f EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

cell surface accessible drug targets; cell surface capturing; glioblastoma; N glycoproteins; N glycoproteome SRM library

Indexed keywords

CELL SURFACE PROTEIN; GLYCOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG TARGETING; EX VIVO STUDY; GENOMICS; GLIOBLASTOMA; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MOLECULAR LIBRARY; PRIORITY JOURNAL; PROTEOMICS; SURVIVAL TIME; TRANSCRIPTOMICS;

AGED; AMINO ACID SEQUENCE; BRAIN NEOPLASMS; GLIOBLASTOMA; GLYCOSYLATION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR TARGETED THERAPY; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOME; PROTEOMICS; STAINING AND LABELING; TUMOR CELLS, CULTURED;

EID: 84867449353     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300360a     Document Type: Article

References (50)

1. Stupp, R.; Mason, W. P.; den Bent, van, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J. B.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma N. Engl. J. Med. 2005, 352, 987-996
2. Ohgaki, H.; Dessen, P.; Jourde, B.; Horstmann, S.; Nishikawa, T.; Di Patre, P.-L.; Burkhard, C.; Schüler, D.; Probst-Hensch, N. M.; Maiorka, P. C.; Baeza, N.; Pisani, P.; Yonekawa, Y.; Yasargil, M. G.; Lütolf, U. M.; Kleihues, P. Genetic pathways to glioblastoma: a population-based study Cancer Res. 2004, 64, 6892-6899
3. Louis, D. N.; Ohgaki, H.; Wiestler, O. D.; Cavenee, W. K.; Burger, P. C.; Jouvet, A.; Scheithauer, B. W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 2007, 114, 97-109
4. Niclou, S. P.; Fack, F.; Rajcevic, U. Glioma proteomics: Status and perspectives J, Proteomics 2010, 73, 1823-1838
5. Bai, R.-Y.; Staedtke, V.; Riggins, G. J. Molecular targeting of glioblastoma: Drug discovery and therapies Trends Mol. Med. 2011, 17, 301-312
6. Kanu, O. O.; Mehta, A.; Di, C.; Lin, N.; Bortoff, K.; Bigner, D. D.; Yan, H.; Adamson, D. C. Glioblastoma multiforme: a review of therapeutic targets Expert Opin. Ther. Targets 2009, 13, 701-718
7. da Cunha, J. P. C.; Galante, P. A. F.; de Souza, J. E.; de Souza, R. F.; Carvalho, P. M.; Ohara, D. T.; Moura, R. P.; Oba-Shinja, S. M.; Marie, S. K. N.; Silva, W. A.; Perez, R. O.; Stransky, B.; Pieprzyk, M.; Moore, J.; Caballero, O.; Gama-Rodrigues, J.; Habr-Gama, A.; Kuo, W. P.; Simpson, A. J.; Camargo, A. A.; Old, L. J.; de Souza, S. J. Bioinformatics construction of the human cell surfaceome Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 16752-16757
8. Yildirim, M. A.; Goh, K.-I.; Cusick, M. E.; Barabási, A.-L.; Vidal, M. Drug-target network Nat. Biotechnol. 2007, 25, 1119-1126
9. Parsons, D. W.; Jones, S.; Zhang, X.; Lin, J. C.-H.; Leary, R. J.; Angenendt, P.; Mankoo, P.; Carter, H.; Siu, I.-M.; Gallia, G. L.; Olivi, A.; Mclendon, R.; Rasheed, B. A.; Keir, S.; Nikolskaya, T.; Nikolsky, Y.; Busam, D. A.; Tekleab, H.; Diaz, L. A.; Hartigan, J.; Smith, D. R.; Strausberg, R. L.; Marie, S. K. N.; Shinjo, S. M. O.; Yan, H.; Riggins, G. J.; Bigner, D. D.; Karchin, R.; Papadopoulos, N.; Parmigiani, G.; Vogelstein, B.; Velculescu, V. E.; Kinzler, K. W. An integrated genomic analysis of human glioblastoma multiforme Science 2008, 321, 1807-1812
10. Rao, S. K.; Edwards, J.; Joshi, A. D.; Siu, I.-M.; Riggins, G. J. A survey of glioblastoma genomic amplifications and deletions J. Neurooncol. 2010, 96, 169-179
11. DAbaco, G. M.; Kaye, A. H. Integrins: molecular determinants of glioma invasion J. Clin. Neurosci. 2007, 14, 1041-1048
12. Reardon, D. A.; Fink, K. L.; Mikkelsen, T.; Cloughesy, T. F.; ONeill, A.; Plotkin, S.; Glantz, M.; Ravin, P.; Raizer, J. J.; Rich, K. M.; Schiff, D.; Shapiro, W. R.; Burdette-Radoux, S.; Dropcho, E. J.; Wittemer, S. M.; Nippgen, J.; Picard, M.; Nabors, L. B. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme J. Clin. Oncol. 2008, 26, 5610-5617
13. Zola, H.; Swart, B.; Banham, A.; Barry, S.; Beare, A.; Bensussan, A.; Boumsell, L.; D Buckley, C; Buhring, H.; Clark, G.; Engel, P.; Fox, D.; Jin, B.; Macardle, P.; Malavasi, F.; Mason, D.; Stockinger, H.; Yang, X. CD molecules 2006 - human cell differentiation molecules J. Immunol. Methods 2007, 319, 1-5
14. Kornblum, H. I.; Geschwind, D. H. Molecular markers in CNS stem cell research: hitting a moving target Nat. Rev. Neurosci. 2001, 2, 843-846
15. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics Nature 2003, 422, 198-207
16. Wollscheid, B.; Bausch-Fluck, D.; Henderson, C.; OBrien, R.; Bibel, M.; Schiess, R.; Aebersold, R.; Watts, J. D. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins Nat. Biotechnol. 2009, 27, 378-386
17. Hofmann, A.; Gerrits, B.; Schmidt, A.; Bock, T.; Bausch-Fluck, D.; Aebersold, R.; Wollscheid, B. Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells Blood 2010, 116, e26-34
18. Ishii, N.; Maier, D.; Merlo, A.; Tada, M.; Sawamura, Y.; Diserens, A. C.; Van Meir, E. G. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines Brain Pathol. 1999, 9, 469-479
19. Diserens, A. C.; de Tribolet, N.; Martin-Achard, A.; Gaide, A. C.; Schnegg, J. F.; Carrel, S. Characterization of an established human malignant glioma cell line: LN-18 Acta Neuropathol. 1981, 53, 21-28
20. Stein, G. H. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro J. Cell Physiol. 1979, 99, 43-54
21. Westermark, B. The deficient density-dependent growth control of human malignant glioma cells and virus-transformed glia-like cells in culture Int. J. Cancer 1973, 12, 438-451
22. Uhlén, M.; Björling, E.; Agaton, C.; Szigyarto, C. A.-K.; Amini, B.; Andersen, E.; Andersson, A.-C.; Angelidou, P.; Asplund, A.; Asplund, C.; Berglund, L.; Bergström, K.; Brumer, H.; Cerjan, D.; Ekström, M.; Elobeid, A.; Eriksson, C.; Fagerberg, L.; Falk, R.; Fall, J.; Forsberg, M.; Björklund, M. G.; Gumbel, K.; Halimi, A.; Hallin, I.; Hamsten, C.; Hansson, M.; Hedhammar, M.; Hercules, G.; Kampf, C.; Larsson, K.; Lindskog, M.; Lodewyckx, W.; Lund, J.; Lundeberg, J.; Magnusson, K.; Malm, E.; Nilsson, P.; Odling, J.; Oksvold, P.; Olsson, I.; Oster, E.; Ottosson, J.; Paavilainen, L.; Persson, A.; Rimini, R.; Rockberg, J.; Runeson, M.; Sivertsson, A.; Sköllermo, A.; Steen, J.; Stenvall, M.; Sterky, F.; Strömberg, S.; Sundberg, M.; Tegel, H.; Tourle, S.; Wahlund, E.; Waldén, A.; Wan, J.; Wernérus, H.; Westberg, J.; Wester, K.; Wrethagen, U.; Xu, L. L.; Hober, S.; Pontén, F. A human protein atlas for normal and cancer tissues based on antibody proteomics Mol. Cell. Proteomics 2005, 4, 1920-1932
23. Rodak, R.; Kubota, H.; Ishihara, H.; Eugster, H.-P.; Könü, D.; Möhler, H.; Yonekawa, Y.; Frei, K. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine J. Neurosurg. 2005, 102, 1055-1068
24. Bock, T.; Bausch-Fluck, D.; Hofmann, A.; Wollscheid, B. CD proteome and beyond-technologies for targeting the immune cell surfaceome Front. Biosci. 2012, 17, 1599-1612
25. Pedrioli, P. G. A.; Eng, J. K.; Hubley, R.; Vogelzang, M.; Deutsch, E. W.; Raught, B.; Pratt, B.; Nilsson, E.; Angeletti, R. H.; Apweiler, R.; Cheung, K.; Costello, C. E.; Hermjakob, H.; Huang, S.; Julian, R. K.; Kapp, E.; McComb, M. E.; Oliver, S. G.; Omenn, G.; Paton, N. W.; Simpson, R.; Smith, R.; Taylor, C. F.; Zhu, W.; Aebersold, R. A common open representation of mass spectrometry data and its application to proteomics research Nat. Biotechnol. 2004, 22, 1459-1466
26. Jain, E.; Bairoch, A.; Duvaud, S.; Phan, I.; Redaschi, N.; Suzek, B. E.; Martin, M. J.; McGarvey, P.; Gasteiger, E. Infrastructure for the life sciences: design and implementation of the UniProt website BMC Bioinf. 2009, 10, 136
27. Keller, A.; Eng, J.; Zhang, N.; Li, X.; Aebersold, R. A uniform proteomics MS/MS analysis platform utilizing open XML file formats Mol. Syst. Biol. 2005, 1, 0017
28. Käll, L.; Krogh, A.; Sonnhammer, E. L. L. A combined transmembrane topology and signal peptide prediction method J. Mol. Biol. 2004, 338, 1027-1036
29. UniProt Consortium The Universal Protein Resource (UniProt) in 2010 Nucleic Acids Res. 2010, 38, D142-8
30. Liu, H.; Sadygov, R. G.; Yates, J. R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76, 4193-4201
31. Lam, H.; Deutsch, E. W.; Eddes, J. S.; Eng, J. K.; King, N.; Stein, S. E.; Aebersold, R. Development and validation of a spectral library searching method for peptide identification from MS/MS Proteomics 2007, 7, 655-667
32. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26, 966-968
33. Louis, D. N. Molecular pathology of malignant gliomas Annu. Rev. Pathol. 2006, 1, 97-117
34. Elschenbroich, S.; Kim, Y.; Medin, J. A.; Kislinger, T. Isolation of cell surface proteins for mass spectrometry-based proteomics Expert Rev. Proteomics 2010, 7, 141-154
35. Kimple, A. J.; Bosch, D. E.; Gigure, P. M.; Siderovski, D. P. Regulators of G-protein signaling and their G? substrates: promises and challenges in their use as drug discovery targets Pharmacol. Rev. 2011, 63, 728-749
36. Gundry, R. L.; Boheler, K. R.; Van Eyk, J. E.; Wollscheid, B. A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface Proteomics: Clin. Appl. 2008, 2, 892-903
37. Thomas, P. D.; Kejariwal, A.; Campbell, M. J.; Mi, H.; Diemer, K.; Guo, N.; Ladunga, I.; Ulitsky-Lazareva, B.; Muruganujan, A.; Rabkin, S.; Vandergriff, J. A.; Doremieux, O. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification Nucleic Acids Res. 2003, 31, 334-341
38. Lundgren, D. H.; Hwang, S.-I.; Wu, L.; Han, D. K. Role of spectral counting in quantitative proteomics Expert Rev. Proteomics 2010, 7, 39-53
39. Desgrosellier, J. S.; Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 2010, 10, 9-22
40. Ranuncolo, S. M.; Ladeda, V.; Specterman, S.; Varela, M.; Lastiri, J.; Morandi, A.; Matos, E.; Bal de Kier Joffé, E.; Puricelli, L.; Pallotta, M. G. CD44 expression in human gliomas J. Surg. Oncol. 2002, 79, 30-35 discussion 35-6
41. Stupp, R.; Hegi, M. E.; Neyns, B.; Goldbrunner, R.; Schlegel, U.; Clement, P. M. J.; Grabenbauer, G. G.; Ochsenbein, A. F.; Simon, M.; Dietrich, P.-Y.; Pietsch, T.; Hicking, C.; Tonn, J.-C.; Diserens, A.-C.; Pica, A.; Hermisson, M.; Krueger, S.; Picard, M.; Weller, M. Phase I/IIa study of cilengitide and Temozolomide with concomitant radiotherapy followed by cilengitide and Temozolomide maintenance therapy in patients with newly diagnosed glioblastoma J. Clin. Oncol. 2010, 28, 2712-2718
42. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: a comprehensive resource for "Omics" research on drugs Nucleic Acids Res. 2010, 39, D1035-D1041
43. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial Mol. Syst. Biol. 2008, 4, 222
44. Anderson, L.; Hunter, C. L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol. Cell. Proteomics 2006, 5, 573-588
45. Picotti, P.; Bodenmiller, B.; Mueller, L. N.; Domon, B.; Aebersold, R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics Cell 2009, 138, 795-806
46. Tanner, S. D.; Bandura, D. R.; Ornatsky, O.; Baranov, V. I.; Nitz, M.; Winnik, M. A. Flow cytometer with mass spectrometer detection for massively multiplexed single-cell biomarker assay Pure Appl. Chem. 2008, 80, 2627-2641
47. Legrain, P.; Aebersold, R.; Archakov, A.; Bairoch, A.; Bala, K.; Beretta, L.; Bergeron, J.; Borchers, C.; Corthals, G. L.; Costello, C. E.; Deutsch, E. W.; Domon, B.; Hancock, W.; He, F.; Hochstrasser, D.; Marko-Varga, G.; Salekdeh, G. H.; Sechi, S.; Snyder, M.; Srivastava, S.; Uhlen, M.; Hu, C. H.; Yamamoto, T.; Paik, Y.-K.; Omenn, G. S. The human proteome project: Current state and future direction Mol. Cell. Proteomics 2011, 10 M111.009993
48. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 2003, 13, 2498-2504
49. Zerrouqi, A.; Van Meir, E. G. A conspiracy of glioma and endothelial cells to invade the normal brain Oncotarget 2011, 2, 1-4
50. Lee, O.-H.; Xu, J.; Fueyo, J.; Fuller, G. N.; Aldape, K. D.; Alonso, M. M.; Piao, Y.; Liu, T.-J.; Lang, F. F.; Bekele, B. N.; Gomez-Manzano, C. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix Mol. Cancer Res. 2006, 4, 915-926